- Home
- SPCE vs FENC Comparison
SPCE vs FENC Comparison
Compare SPCE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.3M | 266.4M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SPCE | FENC |
|---|---|---|
| Price | $2.39 | $6.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $3.86 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.6M | 168.2K |
| Earning Date | 05-14-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.67 |
| EPS | N/A | ★ N/A |
| Revenue | $7,036,000.00 | ★ $47,538,000.00 |
| Revenue This Year | N/A | $75.81 |
| Revenue Next Year | $2,528.09 | $25.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 3.47 | ★ 123.69 |
| 52 Week Low | $2.18 | $4.68 |
| 52 Week High | $5.59 | $9.92 |
Technical Indicators
Market Signals| Indicator | SPCE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | 35.90 |
| Support Level | $2.37 | N/A |
| Resistance Level | $2.68 | $8.27 |
| Average True Range (ATR) | 0.11 | 0.47 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 7.69 | 27.21 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.